Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency

Hormone Research

Volumn 63, Issue 4, 2005, Pages 171-179

  Favier, Judith ^a   Brière, Jean Jacques ^b   Strompf, Laurence ^a   Amar, Laurence ^a   Filali, Mounir ^a   Jeunemaitre, Xavier ^a   Rustin, Pierre ^b   Gimenez Roqueplo, Anne Paule ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cancer genetics; Mitochondria; Paraganglioma; Pheochromocytoma; SDHA; SDHB; SDHC; SDHD

Indexed keywords

FUMARATE HYDRATASE; PROTEIN SUBUNIT; SUCCINATE DEHYDROGENASE;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL FEATURE; COMPLEX II DEFICIENCY; FAMILY; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; KIDNEY TUMOR; LEIGH DISEASE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SHORT SURVEY; SKIN TUMOR; UTERUS TUMOR;

ANIMALS; CITRIC ACID CYCLE; FUMARATE HYDRATASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SUCCINATE DEHYDROGENASE;

EID: 21044457115     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084685     Document Type: Short Survey

References (46)

1. Wallace DC: Mitochondrial diseases in man and mouse. Cell 1999;283:1482-1488.
2. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA: A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003; 3:193-202.
3. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA: Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-410 [Demonstration of germline heterozygous mutation in the FH mitochondrial gene cause susceptibility to HLRCC].
4. Rustin P, Munnich A, Rotig A: Succinate dehydrogenase and human diseases: New insights into a well-known enzyme. Eur J Hum Genet 2002;10:289-291.
5. Ackrell BAC: Cytopathies involving mitochondrial complex II. Mol Aspects Med 2002; 23:369-384.
6. Yankovskaya V, Horsefield R, Tornroth S, Luna-Chavez C, Miyoshi H, Leger C, Byrne B, Cecchini G, Iwata S: Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 2003;299:700-704 [Elucidation of the crystal structure of succinate dehydrogenase in E. coli].
7. Morris AAM, Farnsworth L, Ackrell BAC, Turnbull DM, Birch-Machin MA: The cDNA sequence of the flavoprotein subunit of human heart succinate dehydrogenase. Biochim Biophys Acta 1994;1185:125-128.
8. Kita K, Oya H, Gennis RB, Ackrell BAC, Kasahara M: Human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of iron sulphur (Ip) subunit of liver mitochondria. Biochem Biophys Res Commun 1990; 166:101-108.
9. Au HC, Ream-Robinson D, Bellew LA, Broomfield PLE, Saghbini M, Scheffler IE: Structural organization of the gene encoding the human iron-sulfur subunit of succinate dehydrogenase. Gene 1995;159:249-253.
10. Hirawake H, Taniwaki M, Tamura A, Kojima S, Kita K: Cytochrome b in human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of the components in liver mitochondria and chromosome assignment of the genes for the large (SDHC) and small (SDHD) subunits to 1q21 and 11q23. Cytogenet Cell Genet 1997;79:132-138.
11. Tomitsuka E, Hirawake H, Goto Y, Taniwaki M, Harada S, Kita K: Direct evidence for two distinct forms of the flavoprotein subunit of human mitochondrial complex II (succinate-ubiquinone reductase). J Biochem 2003;134: 191-195.
12. Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, Senoo-Matsuda N, Yanase S, Ayusawa D, Suzuki K: A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 1998;394: 694-697.
13. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-149 [First report of a germline mutation in the SDHA gene causing Leigh syndrome].
14. Parfait B, Chrétien D, Rötig A, Marsac C, Munnich A, Rustin P: Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum Genet 2000;106:236-243.
15. Van Coster R, Seneca S, Smet J, Van Hecke R, Gerlo E, Devreese B, Van Beeumen J, Leroy JG, De Meirleir L, Lissens W: Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II. Am J Med Genet 2003;120A:13-18.
16. Birch-Machin MA, Taylor RW, Cochran B, Ackrell BA, Turnbull DM: Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol 2000;48:330-335.
17. Rustin P, Rötig A: Inborn errors of complex II - Unusual human mitochondrial diseases. Biochim Biophys Acta 2002;1553:117-122.
18. Pellitteri PK, Rinaldo A, Myssiorek D, Jackson G, Bradley PJ, Devaney KO, Shaha AR, Netterville JL, Manni JJ, Ferlito A: Paragangliomas of the head and neck. Oral Oncol 2004; 40:563-575.
19. Rao AB, Koeller KK, Adair CF: Paragangliomas of the head and neck: Radiologic-pathologic correlation. Radiographies 1999;19: 1605-1632.
20. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G: Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: Analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001;86:1480-1486.
21. Van Baars FM, Cremers CWRJ, van den Broek P, Geerts S, Veldman JE: Genetic aspects of non-chromaffin paraganglioma. Hum Genet 1982;60:305-309.
22. Van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ: Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory. Lancet 1989;2:1291-1294 [Demonstration of the autosomal dominant transmission with maternal genomic imprinting in the head and neck paraganglioma families].
23. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, Van der Mey A, Taschner PEM, Rubinstein WS, Myers EN, Richard III CW, Cornelisse CJ, Devilee P, Devlin B: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851 [Identification of SDHD gene as the causative gene for 11q-linked hereditary paraganglioma families].
24. Niemann S, Muller U: Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-270.
25. Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54 [Demonstration of SDHB gene as a susceptibility gene for familial pheochromocytoma and/or paraganglioma].
26. Baysal B, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH, Myers EN, Ferrell RE, Rubinstein WS: Prevalence of SDHB, SDHC and SDHD germline mutations in clinic patients with head and neck paraganghomas. J Med Genet 2002;39:178-183.
27. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lom bardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671.
28. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH: von Hippel-Lindau disease. Lancet 2003;361: 2059-2067.
29. Reynolds RM, Browning GG, Nawroz I, Campbell IW: Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1. Lancet 2003;361:1552-1554.
30. Dluhy RG: Pheochromocytoma - Death of an axiom. N Engl J Med 2002;19:1486-1488.
31. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C: Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466 [Large population study showing that 25% of apparently non-syndromic pheochromocytomas are due to a germline mutation in VHL, RET, SDHB or SDHD genes].
32. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X: COMETE Network. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003;63:5615-5621 [First demonstration that SDHB mutation is a high risk factor for malignancy and extra-adrenal tumors].
33. Amar L, Strompf L, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP: The SDHB and VHL genes should be systematically tested in patients with nonsyndromic pheochromocytoma. J Hypertens 2004;22(suppl 2):S210.
34. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C: European-American Paraganglioma Study Group. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951 [Population-based genetic screening for SDHB and SDHD germline mutations from two registries (Germany, Poland)].
35. Baysal BE: Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39: 617-622.
36. Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE: An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004; 41:703-709.
37. 18F] fluorodopamine positron emission tomographic scanning for diagnostic localization of pheochromocytoma. Hypertension 2001;38:6-8.
38. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689-694.
39. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rotig A, Jeunemaitre X: The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001;69:1186-1197 [First demonstration of the loss of SDH enzymatic activity and the stimulation of hypoxia-angiogenic pathway in the SDH-induced tumors].
40. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin PF, Rotig A, Jeunemaitre X: Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab 2002;87:4771-4774.
41. Rustin P: Mitochondria, from cell death to proliferation. Nat Genet 2002;30:352-353.
42. Pollard PJ, Wortham NC, Tomlinson IPM: The TCA cycle and tumorigenesis: The examples of fumarate hydratase and succinate dehydrogenase. Ann Med 2003;35:632-639.
43. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr: Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002;1:237-246.
44. Hopfl G, Ogunshola O, Gassmann M: HIFs and tumors-causes and consequences. Am J Physiol 2004;286:R608-623.
45. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S: Carotid body tumors in inhabitants of altitudes higher than 2,000 meters above sea level. Head Neck 1998;20:374-378.
46. Bruick RK: Oxygen sensing in the hypoxic response pathway: Regulation of the hypoxia-inducible transcription factor. Genes Dev 2003; 17:2614-2623.